Seinni bylgjan er hafin

á COVID 19

En vonirnar eru að glæðast með bóluefnið

Weeks after the global community began to reopen, there are signs of a resurgence.

New cases and hospitalizations are aggressively sweeping across Florida, California, Texas, Alaska, Arkansas, Kentucky, Mississippi, North Carolina, Oregon, South Carolina, and Utah.

Brazil, the UK, and China are reporting higher case counts, as the world nears the eight million-case mark. It’s all leading to fears the global community may need to shut down again in an attempt to stop an unstoppable virus until we have a vaccine in hand.

- United States is up to 2.094 million cases
- Brazil is now up to 867,624
- Russia is up to 536,484
- India is up to 332,424
- The UK is up to 297,342
- Spain is up to 243,928

And numbers are only likely to surge until there’s a vaccine in hand.

However, even in times of panic, there are opportunities to be well aware of.

Moderna Inc. (MRNA)

Reportedly, Israel is in advanced talks with Moderna to buy its coronavirus vaccine, which is entering the final stage of testing. This news comes after Moderna announced it planned to start a trial of 30,000 volunteers for its vaccine in July.

And, according to the company, it has finalized Phase 3 study protocols based on feedback from the US FDA. It has also completed manufacture of the vaccine required to start the Phase 3 study. The Company expects dosing in the Phase 3 study to begin in July.

Alpha Pro Tech (APT)

With a resurgence of cases, we’re likely to see a major pickup in face mask demand, too. Lloyd Hoffman, President and CEO of Alpha Pro Tech, commented, “The unprecedented surge in demand for our personal protective equipment, otherwise known as PPE, resulting from the outbreak of the coronavirus, COVID-19, particularly our N-95 Particulate Respirator face mask and face shields, drove quarterly sales and significantly higher gross profit for the first quarter.”

Teladoc Health (TDOC)

Telehealth stocks are likely to push higher, too.

Analysts at Forrester say virtual care visits could soar to one billion this year.

"The critical need for social distancing among physicians and patients will drive unprecedented demand for telehealth, which involves the use of communication systems and networks to enable either a synchronous or asynchronous session between the patient and provider," said Victor Camlek, healthcare principal analyst at Frost & Sullivan, as quoted by Healthcare IT News.